Download PDF
Thromb Haemost 1998; 79(06): 1126-1129
DOI: 10.1055/s-0037-1615028
Rapid Communication
Schattauer GmbH

Polymorphism of the Platelet Glycoprotein IIIa Gene in Patients with Coronary Stenosis

Miguel Garcia-Ribes
1   From the Nutrition and Cardiovascular Risk Unit, Spain
,
Domingo Gonzalez-Lamuño
1   From the Nutrition and Cardiovascular Risk Unit, Spain
,
Rafael Hernandez-Estefania
1   From the Nutrition and Cardiovascular Risk Unit, Spain
,
Thierry Colman
3   Hemodynamics Unit, Santander, Spain
,
Miguel Pocovi
5   Dept. of Biochemistry and Molecular Biology, University of Zaragoza, Spain
,
Miguel Delgado-Rodriguez
2   Division of Preventive Medicine and Public Health, University of Cantabria, Spain
,
Miguel Garcia-Fuentes
1   From the Nutrition and Cardiovascular Risk Unit, Spain
,
Jose M. Revuelta
1   From the Nutrition and Cardiovascular Risk Unit, Spain
4   Division of Cardiovascular Surgery, Hospital Universitario Marques de Valdecilla, Santander, Spain
› Author Affiliations
Further Information

Publication History

Received 13 November 1997

Accepted after resubmission 24 February 1998

Publication Date:
07 December 2017 (online)

    Permissions and Reprints

Summary

Based on genetic variability, structural differences in the glycoprotein IIb/IIIa platelet receptor for adhesive proteins result in individual differences in the thrombogenicity of platelets. Recent studies suggest a controversial association between a genetic polymorphism of the glycoprotein IIIa gene (PlA2) and the risk of coronary artery disease. In our study, the prevalence of the PlA2 allele in a group of patients undergoing percutaneous coronary revascularization was 37%, a value significantly higher than in controls [13%, odds ratio (OR) = 3.93, 95% CI, 1.84 to 8.53] suggesting a significant association between this polymorphism and documented coronary stenosis, which is strongest among <60 years old patients (OR = 12.30, 95% CI, 2.98 to 70.93). This polymorphism represents an inherited risk factor for severe cardiovascular disease due to coronary occlusion.

 

  • References

  • 1 Scharf RE, Torner A, Marzec UM, Teirstein PS, Ruggeri ZM, Herker LA. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. Arterioscler Thromb 1992; 12: 1475-87.
    CrossrefPubMedGoogle Scholar
  • 2 Hantgan RR, Hindriks G, Taylor RG, Sixma JJ, de Groot PG. Glycoprotein IIb, von Willebrand factor, and glycoprotein IIb/IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Blood 1990; 76: 345-53.
    PubMedGoogle Scholar
  • 3 Lages B, Weiss HJ. Evidence for a role of glycoprotein IIb/IIIa, distinct from its ability to support aggregation, in platelet activation by ionophores in the presence of extracellular divalent cations. Blood 1994; 83: 2549-59.
    PubMedGoogle Scholar
  • 4 Coller BS, Kutok JL, Scudder LE, Galanakis DK, West SM, Rudomen GS, Springer KT. Studies of activated GP IIb/IIIa receptors on the luminal surface of adherent platelets. Paradoxical loss of luminal receptors when platelets adhere to high density fibrinogen. J Clin Invest 1993; 92: 2796-806.
    CrossrefPubMedGoogle Scholar
  • 5 Ruggeri ZM. Mechanism of shear-induced platelet adhesion and aggregation. Thromb Haemost 1993; 70: 119-23.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Shattil SJ. Regulation of platelet anchorage and signaling for integrin by integrin αIIb/βIIIa. Thromb Haemost 1993; 70: 224-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Kunicki TJ. Biochemistry of platelet-associated isoantigens. In: Platelet immunobiology: molecular and clinical aspects. Kunicki TJ, George JN. eds. Philadelphia: Lippincott; 1989. pp 99-120.
    Google Scholar
  • 8 Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996; 334: 1090-4.
    CrossrefPubMedGoogle Scholar
  • 9 Carter AM, Ossei-Gerning N. Platelet glycoprotein IIIa PlA polymorphism and myocardial infarction [letter]. N Engl J Med 1996; 335: 1071.
    CrossrefPubMedGoogle Scholar
  • 10 Bray PF, Weiss EJ, Tayback M, Goldschmidt-Clermont PJ. PlA1/A2 polymorphism of platelet glycoprotein IIIa and risk of cardiovascular disease [letter]. Lancet 1997; 349: 1100-1.
    CrossrefPubMedGoogle Scholar
  • 11 Carter AM, Ossei-Gerning N, Grant PJ. Platelet glycoprotein IIIa PlA polymorphism in young men with myocardial infarction. Lancet 1996; 348: 485-6.
    PubMedGoogle Scholar
  • 12 Carter AM, Ossei-Gerning N, Wilson IJ, Grant PJ. Association of the platelet PlA polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bβ448 polymorphism with myocardial infarction and extent of coronary artery disease. Circulation 1997; 96: 1424-31.
    CrossrefPubMedGoogle Scholar
  • 13 Marian AJ, Brugada R, Kleiman NS. Platelet glycoprotein IIIa PlA polymorphism and myocardial infarction [letter]. N Engl J Med 1996; 335: 1071.
    CrossrefPubMedGoogle Scholar
  • 14 Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K. PlA1/A2 polymorphism of platelet glycoprotein IIIa and risk of myocardial infarction, stroke, and venous thrombosis. Lancet 1997; 349: 385-9.
    CrossrefPubMedGoogle Scholar
  • 15 Samani NJ, Lodwick D. Glycoprotein IIIa polymorphism and risk of myocardial infarction. Cardiovasc Res 1997; 33: 693-7.
    CrossrefPubMedGoogle Scholar
  • 16 Fuster V, Lewis A. Conner Memorial Lecture. Mechanism leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994; 90: 2126-46.
    CrossrefPubMedGoogle Scholar
  • 17 Fuster V, Braunwald E. Unstable Angina. Definition, pathogenesis, and classification. In: Atherosclerosis and coronary artery disease. Fuster V, Ross R, Topol EJ. eds. Philadelphia: Lippincott-Raven Publishers; 1996. pp 1285-97.
    Google Scholar
  • 18 Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA for human nucleated cell. Nucleic Acids Res 1988; 16: 1215.
    CrossrefPubMedGoogle Scholar
  • 19 Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989; 129: 125-37.
    CrossrefPubMedGoogle Scholar
  • 20 Von der Borne AEG, Decary F. Nomenclature of platelet specific antigen. Transfusion 1990; 30: 477.
    PubMedGoogle Scholar
  • 21 Simsek S, Faber NM, Bleeker PM. Determination of human platelet antigen frequencies in the Dutch population by immunophenotyping and DNA (allele-specific restriction enzyme) analysis. Blood 1993; 81: 835-40.
    PubMedGoogle Scholar
  • 22 Kim HO, Jin Y, Kickler TS, Blakemore K, Kwon OH, Bray PF. Gene frequencies of the five major human platelet antigens in African American, white and Korean populations. Transfusion 1995; 35: 963-7.
    PubMedGoogle Scholar
  • 23 Wacholder S, McLaughlin JK, Silverman DT, Mandel JS. Selection of controls in case-controls studies. I. Principles. Am J Epidemiol 1992; 135: 1019-28.
    CrossrefPubMedGoogle Scholar
  • 24 Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242-250 310-8.
    CrossrefPubMedGoogle Scholar
  • 25 Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995; 332: 1553-9.
    CrossrefPubMedGoogle Scholar